Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review

Breast cancer is the leading cause of death in women from 20 to 59 years old. The conventional treatment includes surgery, chemotherapy, hormonal therapy, and immunotherapy. This immunotherapy is based on administering monoclonal therapeutic antibodies (passive) or vaccines (active) with therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolás-Morales, María Lilia, Luisa-Sanjuan, Arianna, Gutiérrez-Torres, Mayralina, Vences-Velázquez, Amalia, Ortuño-Pineda, Carlos, Espinoza-Rojo, Mónica, Navarro-Tito, Napoleón, Cortés-Sarabia, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416350/
https://www.ncbi.nlm.nih.gov/pubmed/36016136
http://dx.doi.org/10.3390/vaccines10081249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416350/
https://www.ncbi.nlm.nih.gov/pubmed/36016136
http://dx.doi.org/10.3390/vaccines10081249

Ejemplares similares